Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.
about
New concepts of resistance in the treatment of Helicobacter pylori infectionsPharmacology of proton pump inhibitorsPharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific RegionTreatment of Helicobacter pylori infection: Current and future insightsCYP2C19 polymorphism influences Helicobacter pylori eradicationPhenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals.Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect.PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19.Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of LifePharmacokinetics and pharmacodynamics of the proton pump inhibitors.Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: a randomized, open-labeled, two-way crossover studyInterindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase contentIncreased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers.How May Proton Pump Inhibitors Impair Cardiovascular Health?The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patientsPerioperative genomic profiles using structure-specific oligonucleotide probes.Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials.Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapyAcid peptic diseases: pharmacological approach to treatment.Rapid and ultra-rapid metabolizers with CYP2C19*17 polymorphism do not respond to standard therapy with proton pump inhibitors.
P2860
Q24622513-EF5D0F63-1600-4DE6-8C57-48397D2E2D8CQ24634771-3F0E2D99-F4C1-4C27-AAB8-20C080F54411Q26765113-30E57307-07F8-4180-A0B7-CC84B935F538Q26769707-B9CCC69B-5C4F-431F-8CC0-4863C5D6D231Q27005916-F75DE346-2294-486F-94A5-A1DE6A584131Q33290485-48D43D4B-A92F-40C0-880C-6417A20BA498Q33891049-AD9ED6A5-876B-42D2-A5B5-10628264AC56Q35952367-3E3AE96A-1EA1-435E-8324-32E7F8816D1BQ36429167-FA9F7797-CB67-45F8-8A53-B80BF28B88E6Q36542670-075EB657-887D-444B-A44D-EC99592D9F51Q36576842-A851B21B-7163-4D5B-9B0C-5DC774D5199DQ36643041-54774A9B-659C-4E75-BBC6-BAC3A22E6EC5Q36729190-64F6CE38-F662-431B-B4D3-52E7DEFF3E3EQ36892867-85BF953E-545E-487C-814B-024636B53F49Q36974866-6A1B026E-3999-493A-AC96-DA17B8ABD598Q37161518-8EF26CAA-FD2E-4296-9367-85F664AB7F3AQ37376199-AD234B5E-DFC2-4BFF-BD29-2538C567F1CEQ37671220-D25D5DE3-5EDA-42EF-8CFC-0C94532EDD49Q37714369-844A7EDB-0D57-429E-8D77-8FEB95C54464Q37913063-92F6750A-AC6A-48F8-8546-A8A8EB15E4A7Q40389903-091FA849-FAA3-4DA0-83D6-E5CB66D1919F
P2860
Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Clinical impact of CYP2C19 pol ...... a review of a special problem.
@ast
Clinical impact of CYP2C19 pol ...... a review of a special problem.
@en
type
label
Clinical impact of CYP2C19 pol ...... a review of a special problem.
@ast
Clinical impact of CYP2C19 pol ...... a review of a special problem.
@en
prefLabel
Clinical impact of CYP2C19 pol ...... a review of a special problem.
@ast
Clinical impact of CYP2C19 pol ...... a review of a special problem.
@en
P356
P1476
Clinical impact of CYP2C19 pol ...... a review of a special problem
@en
P2093
P304
P356
10.5414/CPP44297
P577
2006-07-01T00:00:00Z